Johannes T. Brouwer - Concepedia

Author

Johannes T. Brouwer

Also Known As

J BROUWER, J T Brouwer, J. Brouwer, J. T. Brouwer, J.M. Vrolijk, J.T. Brouwer, Johannes Brouwer, Johannes T Brouwer, Johannes T. Brouwer, L. Jutten-Brouwer

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam Reinier de Graaf Hospital Leiden University Medical Center University Medical Center Groningen

About

Johannes T. Brouwer is an author at Erasmus MC specializing in medicine, hepatitis, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.5K
2	Hepatology	11	13	1.1K
3	Public Health	1	1	102
4	Gastroenterology	1	1	46
5	Health Policy	1	1	102

Johannes T. Brouwer

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1 Ynto S. de Boer, Nicole M. F. van Gerven, Antonie Zwiers, Gastroenterology Genome-wide Association StudyAutoimmune DiseaseGenotype-phenotype AssociationGeneticsGenetic Epidemiology	2014	298
Suicide associated with alfa-interferon therapy for chronic viral hepatitis Harry L.A. Janssen, Johannes T. Brouwer, Rose C. van der Mast, Journal of Hepatology HepatologyViral HepatitisSuicideHepatitisChronic Viral Hepatitis	1994	233
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission Nicole M. F. van Gerven, Bart J. Verwer, Birgit I. Lissenberg‐Witte, Journal of Hepatology HepatologyAutoimmune DiseaseImmunosuppressive TherapyImmunologyHepatitis	2012	225
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C Giovanna Fattovich, G. Giustina, Françoise Degos, Journal of Hepatology HepatologyLiver PhysiologyCirrhosis Type CImmunologyHepatitis	1997	201
Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands Nicole M. F. van Gerven, Bart J. Verwer, Birgit I. Lissenberg‐Witte, Scandinavian Journal of Gastroenterology	2014	184
Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial Tekla Gj Van Rossum, Arnold G. Vulto, Wim C.J. Hop, Journal of Gastroenterology and Hepatology	1999	180
A psychometric comparison of health-related quality of life measures in chronic liver disease Gülseren Ünal, Josien B. de Boer, Gerard Borsboom, Journal of Clinical Epidemiology Quality Of LifeLife SatisfactionPsychometric ComparisonLife AssessmentHealth Policy	2001	102
Carbohydrate antigen 19‐9 is extremely elevated in polycystic liver disease Esmé Waanders, Loes van Keimpema, Johannes T. Brouwer, Liver International	2009	90
Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT Johannes T. Brouwer, Bettina E. Hansen, Hubert G.M. Niesters, Journal of Hepatology HepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitis	1999	82
Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: A randomized phase II trial Hans Orlent, Bettina E. Hansen, Marc Willems, Journal of Hepatology HepatologyHepatitis CViral HepatitisLiver PhysiologyPharmacology	2006	78

Page 1